carbon monoxide has been researched along with Lymphangiomyomatosis in 7 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Angiotensin-converting enzyme inhibitors may slow decline of pulmonary function in patients with lymphangioleiomyomatosis not treated with sirolimus." | 3.91 | Angiotensin-converting enzyme inhibitors may affect pulmonary function in lymphangioleiomyomatosis. ( Moss, J; Pacheco-Rodriguez, G; Steagall, WK; Stylianou, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freitas, CSG | 1 |
| Baldi, BG | 1 |
| Jardim, C | 1 |
| Araujo, MS | 1 |
| Sobral, JB | 1 |
| Heiden, GI | 1 |
| Kairalla, RA | 1 |
| Souza, R | 1 |
| Carvalho, CRR | 1 |
| Taveira-DaSilva, AM | 1 |
| Julien-Williams, P | 1 |
| Jones, AM | 1 |
| Stylianou, M | 2 |
| Moss, J | 3 |
| Wu, X | 1 |
| Xu, W | 1 |
| Wang, J | 1 |
| Tian, X | 1 |
| Tian, Z | 1 |
| Xu, K | 1 |
| Steagall, WK | 1 |
| Pacheco-Rodriguez, G | 1 |
| Cottin, V | 1 |
| Harari, S | 1 |
| Humbert, M | 1 |
| Mal, H | 1 |
| Dorfmüller, P | 1 |
| Jaïs, X | 1 |
| Reynaud-Gaubert, M | 1 |
| Prevot, G | 1 |
| Lazor, R | 2 |
| Taillé, C | 1 |
| Lacronique, J | 2 |
| Zeghmar, S | 1 |
| Simonneau, G | 1 |
| Cordier, JF | 2 |
| Valeyre, D | 1 |
| Wallaert, B | 1 |
| Urban, T | 1 |
| Avila, NA | 1 |
| Chen, CC | 1 |
| Chu, SC | 1 |
| Wu, M | 1 |
| Jones, EC | 1 |
| Neumann, RD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomised, Double Blind, Placebo Controlled Trial of Doxycycline in Lymphangioleiomyomatosis.[NCT00989742] | Phase 4 | 24 participants (Actual) | Interventional | 2009-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 other studies available for carbon monoxide and Lymphangiomyomatosis
| Article | Year |
|---|---|
Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method.
Topics: Adult; Carbon Monoxide; Echocardiography; Female; Humans; Hypertension, Pulmonary; Lymphangioleiomyo | 2017 |
Rates of change in FEV
Topics: Adolescent; Adult; Carbon Monoxide; Disease Progression; Female; Forced Expiratory Volume; Humans; L | 2018 |
Clinical characteristics in lymphangioleiomyomatosis-related pulmonary hypertension: an observation on 50 patients.
Topics: Adult; Carbon Monoxide; Echocardiography; Exercise Test; Female; Hemodynamics; Humans; Hypertension, | 2019 |
Angiotensin-converting enzyme inhibitors may affect pulmonary function in lymphangioleiomyomatosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Carbon Monoxide; Disease Progression; Female; Forced Expir | 2019 |
Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients.
Topics: Adult; Breath Tests; Carbon Monoxide; Cardiac Catheterization; Exercise Test; Female; Hemodynamics; | 2012 |
Low initial KCO predicts rapid FEV1 decline in pulmonary lymphangioleiomyomatosis.
Topics: Adult; Age of Onset; Carbon Monoxide; Female; Forced Expiratory Volume; Humans; Lung Neoplasms; Lymp | 2004 |
Pulmonary lymphangioleiomyomatosis: correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests.
Topics: Adult; Analysis of Variance; Carbon Monoxide; Female; Forced Expiratory Volume; Humans; Lung Neoplas | 2000 |